Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2026-2032

October 2026 | 116 pages | ID: GE07906B413EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Neuromodulation Devices and Implantable Infusion Pumps market size is predicted to grow from US$ 5745 million in 2025 to US$ 8792 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Neuromodulation Devices and Implantable Infusion Pumps are implantable medical systems designed to provide long-term regulation of nervous-system function through electrical stimulation or targeted drug delivery. Neuromodulation systems generally comprise an implantable pulse generator, leads, extensions, patient controllers and clinician programming platforms, and include spinal cord stimulation, deep brain stimulation, dorsal root ganglion stimulation, vagus nerve stimulation and sacral neuromodulation. Implantable infusion pumps incorporate a drug reservoir, precision pumping mechanism, catheter and programmable controller to deliver medication continuously or according to a prescribed schedule to an intrathecal or other targeted site. These products are primarily used for chronic intractable pain, movement disorders such as Parkinson’s disease, epilepsy, bladder and bowel dysfunction, cancer pain and severe spasticity. Their central value lies in delivering adjustable, reversible and durable therapy with greater anatomical precision.In 2025, global Neuromodulation Devices and Implantable Infusion Pumps production reached approximately 279.63 k units.The average gross profit margin of this product is 75%.

Population aging, the rising burden of chronic pain and neurological disease, and growing concern regarding long-term systemic medication use are creating a durable demand base. Neuromodulation can act directly on selected neural pathways and allows stimulation settings to be adjusted according to patient response, while intrathecal infusion delivers medication near the spinal cord and may support patients who receive insufficient relief or unacceptable adverse effects from oral therapy. Continued advances in stimulation waveforms, directional leads, miniaturized power systems and digital programming are expanding treatment beyond traditional refractory cases toward more precisely selected patient groups. The industry is consequently evolving from a standalone implant market into a long-term ecosystem combining implantation, programming, follow-up services and replacement components.

Because these products require surgical implantation and remain in the body for extended periods, adoption is influenced by patient selection, specialist availability, reimbursement and willingness to undergo an implant procedure. Infection, lead migration or fracture, premature battery depletion, declining therapeutic effect and discomfort at the implant site may require reprogramming, revision or additional surgery. Implantable infusion pumps introduce further risks involving catheter blockage, underdelivery or overdose, pump interruption and refill management. Rigorous regulatory review, long-term reliability testing and continuous adverse-event surveillance increase development and compliance costs, making manufacturing quality and post-market support essential to customer confidence.

Hospitals and physicians are moving beyond evaluating whether a system can generate stimulation and are focusing increasingly on whether it can provide durable, stable and manageable clinical outcomes. Demand is shifting toward smaller implants, longer operating life, lower charging burden, MRI compatibility and support for multiple therapy programs. Intelligent systems capable of sensing patient status, refining stimulation parameters and preserving treatment records will strengthen individualized care. Multidisciplinary collaboration among pain centers, neurosurgery, functional neurology, urology and rehabilitation departments is also increasing, making patient-selection support, physician training, programming services and long-term follow-up as influential as the device itself in purchasing decisions.

LP Information, Inc. (LPI) ' newest research report, the “Neuromodulation Devices and Implantable Infusion Pumps Industry Forecast” looks at past sales and reviews total world Neuromodulation Devices and Implantable Infusion Pumps sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuromodulation Devices and Implantable Infusion Pumps sales for 2026 through 2032. With Neuromodulation Devices and Implantable Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation Devices and Implantable Infusion Pumps industry.

This Insight Report provides a comprehensive analysis of the global Neuromodulation Devices and Implantable Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromodulation Devices and Implantable Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuromodulation Devices and Implantable Infusion Pumps market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation Devices and Implantable Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation Devices and Implantable Infusion Pumps.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

  • Neuromodulation Devices
  • Implantable Infusion Pumps

Segmentation by Target Anatomy:

  • Pain Management
  • Movement Disorder
  • Spasticity
  • Urinary and Bowel Dysfunction
  • Other

Segmentation by Implantable Pump Type:

  • Rechargeable Implant
  • Non-rechargeable Implant

Segmentation by Application:

  • Chronic Pain Therapy
  • Neurological Disease Management
  • Intrathecal Drug Delivery
  • Functional Neuromodulation
  • Other

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Medtronic
  • Boston Scientific
  • Abbott
  • Nevro
  • LivaNova
  • Synapse Biomedical
  • Flowonix
  • Tricumed
  • PINS Medical
  • SceneRay
  • MicroPort
  • Beijing Rishena

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
  • What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
  • How does Neuromodulation Devices and Implantable Infusion Pumps break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2021, 2025 & 2032
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
  2.2.1 Neuromodulation Devices
  2.2.2 Implantable Infusion Pumps
  2.2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
    2.2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2021-2026)
2.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Target Anatomy
  2.3.1 Pain Management
  2.3.2 Movement Disorder
  2.3.3 Spasticity
  2.3.4 Urinary and Bowel Dysfunction
  2.3.5 Other
  2.3.6 Neuromodulation Devices and Implantable Infusion Pumps Sales by Target Anatomy
    2.3.6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Target Anatomy (2021-2026)
    2.3.6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Target Anatomy (2021-2026)
    2.3.6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Target Anatomy (2021-2026)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Implantable Pump Type
  2.4.1 Rechargeable Implant
  2.4.2 Non-rechargeable Implant
  2.4.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Implantable Pump Type
    2.4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type (2021-2026)
    2.4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Implantable Pump Type (2021-2026)
    2.4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Implantable Pump Type (2021-2026)
2.5 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
  2.5.1 Chronic Pain Therapy
  2.5.2 Neurological Disease Management
  2.5.3 Intrathecal Drug Delivery
  2.5.4 Functional Neuromodulation
  2.5.5 Other
  2.5.6 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
    2.5.6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2021-2026)
    2.5.6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2021-2026)
    2.5.6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
  3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2021-2026)
  3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2021-2026)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2021-2026)
  3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026)
  3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
  3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION

4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2021-2026)
  4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2021-2026)
  4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth

5 AMERICAS

5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
  5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
  6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026)
  6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
  7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
  8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026)
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer

12 WORLD FORECAST REVIEW FOR NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY GEOGRAPHIC REGION

12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
  12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2027-2032)
  12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type (2027-2032)
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Medtronic
  13.1.1 Medtronic Company Information
  13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Medtronic Main Business Overview
  13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
  13.2.1 Boston Scientific Company Information
  13.2.2 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.2.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Boston Scientific Main Business Overview
  13.2.5 Boston Scientific Latest Developments
13.3 Abbott
  13.3.1 Abbott Company Information
  13.3.2 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Abbott Main Business Overview
  13.3.5 Abbott Latest Developments
13.4 Nevro
  13.4.1 Nevro Company Information
  13.4.2 Nevro Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.4.3 Nevro Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Nevro Main Business Overview
  13.4.5 Nevro Latest Developments
13.5 LivaNova
  13.5.1 LivaNova Company Information
  13.5.2 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.5.3 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 LivaNova Main Business Overview
  13.5.5 LivaNova Latest Developments
13.6 Synapse Biomedical
  13.6.1 Synapse Biomedical Company Information
  13.6.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.6.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Synapse Biomedical Main Business Overview
  13.6.5 Synapse Biomedical Latest Developments
13.7 Flowonix
  13.7.1 Flowonix Company Information
  13.7.2 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.7.3 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Flowonix Main Business Overview
  13.7.5 Flowonix Latest Developments
13.8 Tricumed
  13.8.1 Tricumed Company Information
  13.8.2 Tricumed Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.8.3 Tricumed Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Tricumed Main Business Overview
  13.8.5 Tricumed Latest Developments
13.9 PINS Medical
  13.9.1 PINS Medical Company Information
  13.9.2 PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.9.3 PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 PINS Medical Main Business Overview
  13.9.5 PINS Medical Latest Developments
13.10 SceneRay
  13.10.1 SceneRay Company Information
  13.10.2 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.10.3 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 SceneRay Main Business Overview
  13.10.5 SceneRay Latest Developments
13.11 MicroPort
  13.11.1 MicroPort Company Information
  13.11.2 MicroPort Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.11.3 MicroPort Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 MicroPort Main Business Overview
  13.11.5 MicroPort Latest Developments
13.12 Beijing Rishena
  13.12.1 Beijing Rishena Company Information
  13.12.2 Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
  13.12.3 Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Beijing Rishena Main Business Overview
  13.12.5 Beijing Rishena Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Neuromodulation Devices
Table 4. Major Players of Implantable Infusion Pumps
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & ($ million)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026)
Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Pain Management
Table 11. Major Players of Movement Disorder
Table 12. Major Players of Spasticity
Table 13. Major Players of Urinary and Bowel Dysfunction
Table 14. Major Players of Other
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Target Anatomy (2021-2026) & (Unit)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Target Anatomy (2021-2026)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Target Anatomy (2021-2026) & ($ million)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Target Anatomy (2021-2026)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Target Anatomy (2021-2026) & (USD/Unit)
Table 20. Major Players of Rechargeable Implant
Table 21. Major Players of Non-rechargeable Implant
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Implantable Pump Type (2021-2026) & (Unit)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type (2021-2026)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Implantable Pump Type (2021-2026) & ($ million)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Implantable Pump Type (2021-2026)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Implantable Pump Type (2021-2026) & (USD/Unit)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sale by Application (2021-2026) & (Unit)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2021-2026)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & ($ million)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2026)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2021-2026) & (USD/Unit)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2021-2026) & (Unit)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2021-2026)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2021-2026) & (USD/Unit)
Table 37. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 38. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 39. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2021-2026) & (Unit)
Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Geographic Region (2021-2026)
Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country/Region (2021-2026) & (Unit)
Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2021-2026)
Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 51. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026)
Table 52. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 54. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 55. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit)
Table 56. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2026)
Table 57. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 59. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 60. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 61. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 63. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 64. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit)
Table 65. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit)
Table 67. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit)
Table 68. Key Market Drivers & Growth Opportunities of Neuromodulation Devices and Implantable Infusion Pumps
Table 69. Key Market Challenges & Risks of Neuromodulation Devices and Implantable Infusion Pumps
Table 70. Key Industry Trends of Neuromodulation Devices and Implantable Infusion Pumps
Table 71. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 74. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2027-2032) & (Unit)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 78. Americas Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2027-2032) & (Unit)
Table 80. APAC Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 82. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit)
Table 84. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2027-2032) & (Unit)
Table 86. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2027-2032) & (Unit)
Table 88. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 91. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Boston Scientific Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 96. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. Abbott Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 101. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. Abbott Main Business
Table 103. Abbott Latest Developments
Table 104. Nevro Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Nevro Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 106. Nevro Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. Nevro Main Business
Table 108. Nevro Latest Developments
Table 109. LivaNova Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 111. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. LivaNova Main Business
Table 113. LivaNova Latest Developments
Table 114. Synapse Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 116. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Synapse Biomedical Main Business
Table 118. Synapse Biomedical Latest Developments
Table 119. Flowonix Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Flowonix Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 121. Flowonix Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. Flowonix Main Business
Table 123. Flowonix Latest Developments
Table 124. Tricumed Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. Tricumed Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 126. Tricumed Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. Tricumed Main Business
Table 128. Tricumed Latest Developments
Table 129. PINS Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 130. PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 131. PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. PINS Medical Main Business
Table 133. PINS Medical Latest Developments
Table 134. SceneRay Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 135. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 136. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. SceneRay Main Business
Table 138. SceneRay Latest Developments
Table 139. MicroPort Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 140. MicroPort Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 141. MicroPort Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 142. MicroPort Main Business
Table 143. MicroPort Latest Developments
Table 144. Beijing Rishena Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 145. Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 146. Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 147. Beijing Rishena Main Business
Table 148. Beijing Rishena Latest Developments

LIST OF FIGURES

Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2021-2032 (Unit)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2025)
Figure 10. Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Neuromodulation Devices
Figure 12. Product Picture of Implantable Infusion Pumps
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2026
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Pain Management
Figure 16. Product Picture of Movement Disorder
Figure 17. Product Picture of Spasticity
Figure 18. Product Picture of Urinary and Bowel Dysfunction
Figure 19. Product Picture of Other
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Target Anatomy in 2026
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Target Anatomy (2021-2026)
Figure 22. Product Picture of Rechargeable Implant
Figure 23. Product Picture of Non-rechargeable Implant
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Implantable Pump Type in 2026
Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Implantable Pump Type (2021-2026)
Figure 26. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Chronic Pain Therapy
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Chronic Pain Therapy (2021-2026) & (Unit)
Figure 28. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Neurological Disease Management
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Neurological Disease Management (2021-2026) & (Unit)
Figure 30. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Intrathecal Drug Delivery
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Intrathecal Drug Delivery (2021-2026) & (Unit)
Figure 32. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Functional Neuromodulation
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Functional Neuromodulation (2021-2026) & (Unit)
Figure 34. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2021-2026) & (Unit)
Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2025)
Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2025
Figure 38. Neuromodulation Devices and Implantable Infusion Pumps Sales by Company in 2025 (Unit)
Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2025
Figure 40. Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company in 2025 ($ millions)
Figure 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2025
Figure 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 45. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2021-2026 (Unit)
Figure 51. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021-2026 ($ millions)
Figure 52. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2025
Figure 53. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Figure 54. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 55. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 56. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2025
Figure 61. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2026)
Figure 62. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 63. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 64. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 68. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2025
Figure 72. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021-2026)
Figure 73. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 74. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 75. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 76. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026)
Figure 83. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2026
Figure 89. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 90. Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 91. Channels of Distribution
Figure 92. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Forecast by Region (2027-2032)
Figure 93. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2027-2032)